UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

No cure exists, but medications and management strategies may temporarily improve the symptoms. The landscape shifted in 2021, when the FDA approved Aduhelm, the first Alzheimer’s drug showing ...

Eli Lilly’s stock price jumped 6.7% after it announced positive results from a trial of one new Alzheimer’s drug, increasing the company’s value by more than $25 billion that day.